Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HRH3 | Q9Y5N1 | 3/20 | 0.56 |
| ▸ | STK17A | Q9UEE5 | 1/20 | 0.44 |
| ▸ | IRAK4 | Q9NWZ3 | 1/20 | 0.43 |
| ▸ | HRH4 | Q9H3N8 | 2/20 | 0.41 |
| ▸ | PIM1 | P11309 | 2/20 | 0.40 |
| ▸ | PIM2 | Q9P1W9 | 2/20 | 0.40 |
| ▸ | MEN1 | O00255 | 1/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.40 |
| ▸ | HPGD | P15428 | 1/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.40 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.40 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.39 |
| ▸ | HSP90AB1 | P08238 | 1/20 | 0.39 |
| ▸ | TLR8 | Q9NR97 | 2/20 | 0.39 |
| ▸ | NUDT1 | P36639 | 1/20 | 0.39 |
| ▸ | CHEK1 | O14757 | 2/20 | 0.37 |
| ▸ | CDK7 | P50613 | 1/20 | 0.36 |
| ▸ | CA12 | O43570 | 1/20 | 0.36 |
| ▸ | CA1 | P00915 | 1/20 | 0.36 |
| ▸ | CA2 | P00918 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29445680 | 1.00 | HRH3 (0.56) | HRH3STK17AIRAK4HRH4PIM1 | |
| SCHEMBL16019054 | 0.94 | HRH3 (0.50) | HRH3STK17AIRAK4HRH4PIM1 | |
| SCHEMBL16019055 | 0.91 | TLR8 (0.51) | HRH3STK17AIRAK4HRH4MEN1 | |
| SCHEMBL16019053 | 0.86 | TLR8 (0.46) | HRH3TLR8 | |
| SCHEMBL2907513 | 0.84 | HRH3 (0.43) | HRH3STK17AIRAK4HRH4PIM1 | |
| SCHEMBL5943488 | 0.78 | NCF1 (0.52) | HRH3IRAK4HRH4PIM1PIM2 | |
| SCHEMBL29625898 | 0.74 | SYK (0.44) | HRH3IRAK4MEN1ALDH1A1HPGD | |
| SCHEMBL31648525 | 0.74 | TLR8 (0.49) | HRH3TLR8 | |
| SCHEMBL8354796 | 0.73 | NCF1 (0.50) | HRH3HRH4HPGDHSD17B10 | |
| SCHEMBL31742466 | 0.72 | HRH3 (0.51) | HRH3STK17AIRAK4HRH4PIM1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20170268042-A1 | PCR METHOD AND PCR KIT | OSAKA UNIVERSITY (JP) | 2017-09-21 | — | — | US | disclosed |
| US-20170268042-A1 | PCR METHOD AND PCR KIT | OSAKA UNIVERSITY (JP) | 2017-09-21 | — | — | US | disclosed |
| US-9057105-B2 | Method for detecting single nucleotide polymorphism in nucleic acid | FURUKAWA ELECTRIC ADVANCED ENGINEERING CO., LTD. (JP) | 2015-06-16 | — | — | US | disclosed |
| US-9057105-B2 | Method for detecting single nucleotide polymorphism in nucleic acid | FURUKAWA ELECTRIC ADVANCED ENGINEERING CO., LTD. (JP) | 2015-06-16 | — | — | US | disclosed |
| US-9057105-B2 | Method for detecting single nucleotide polymorphism in nucleic acid | FURUKAWA ELECTRIC ADVANCED ENGINEERING CO., LTD. (JP) | 2015-06-16 | — | — | US | disclosed |
| US-8911947-B2 | DNA fragment used as attached to 5′ end of primer used in nucleic acid amplification reaction and use of DNA fragment | FURUKAWA ELECTRIC ADVANCED ENGINEERING CO., LTD. (JP) | 2014-12-16 | — | — | US | disclosed |
| US-8911947-B2 | DNA fragment used as attached to 5′ end of primer used in nucleic acid amplification reaction and use of DNA fragment | FURUKAWA ELECTRIC ADVANCED ENGINEERING CO., LTD. (JP) | 2014-12-16 | — | — | US | disclosed |
| US-20140255938-A1 | METHOD FOR DETECTING SINGLE NUCLEOTIDE POLYMORPHISM IN NUCLEIC ACID | OSAKA UNIVERSITY (JP) | 2014-09-11 | — | — | US | disclosed |
| US-20140255938-A1 | METHOD FOR DETECTING SINGLE NUCLEOTIDE POLYMORPHISM IN NUCLEIC ACID | OSAKA UNIVERSITY (JP) | 2014-09-11 | — | — | US | disclosed |
| US-20140255938-A1 | METHOD FOR DETECTING SINGLE NUCLEOTIDE POLYMORPHISM IN NUCLEIC ACID | OSAKA UNIVERSITY (JP) | 2014-09-11 | — | — | US | disclosed |
| EP-2058392-B1 | DNA FRAGMENT USED IN THE FORM ATTACHED TO 5'-TERMINUS OF PRIMER FOR USE IN AMPLIFICATION REACTION OF NUCLEIC ACID, AND USE THEREOF | UNIV OSAKA (JP) | 2011-10-12 | — | — | EP | disclosed |
| US-20100015618-A1 | DNA FRAGMENT USED AS ATTACHED TO 5' END OF PRIMER USED IN NUCLEIC ACID AMPLIFICATION REACTION AND USE OF DNA FRAGMENT | OSAKA UNIVERSITY (JP) | 2010-01-21 | — | — | US | disclosed |
| US-20100015618-A1 | DNA FRAGMENT USED AS ATTACHED TO 5' END OF PRIMER USED IN NUCLEIC ACID AMPLIFICATION REACTION AND USE OF DNA FRAGMENT | OSAKA UNIVERSITY (JP) | 2010-01-21 | — | — | US | disclosed |
| EP-2058392-A1 | DNA FRAGMENT USED IN THE FORM ATTACHED TO 5'-TERMINUS OF PRIMER FOR USE IN AMPLIFICATION REACTION OF NUCLEIC ACID, AND USE THEREOF | Osaka University (JP) | 2009-05-13 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100015618-A1 | DNA FRAGMENT USED AS ATTACHED TO 5' END OF PRIMER USED IN NUCLEIC ACID AMPLIFICATION REACTION AND USE OF DNA FRAGMENT | PCNA, APEX1, RNGTT | HRH3 2165/4885STK17A 4253/4885IRAK4 1199/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.